This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Maintenance Service Contract for Illumina MiSeq and NextSeq
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to maintenance services for the Illumina MiSeq and NextSeq sequencing machines used by the Laboratory of Biochemistry and Molecular Biology (LBMB) at the National Institutes of Health. LBMB conducts fundamental cancer research utilizing advanced techniques including Next Generation Sequencing for genome-wide epigenetic analysis. The maintenance contract ensures the optimal functioning of these critical sequencing instruments, which are essential for the lab’s high-throughput genome sequencing efforts. Interested parties are invited to submit information demonstrating their capability to fulfill the contract, including technical and cost proposals, business certifications, and registrations such as an active System for Award Management (SAM) status. Submissions must be received by May 31, 2026, at 9:00 AM Eastern Time and should reference solicitation number 75N98026Q00422. The government will decide whether to proceed with a competitive or non-competitive procurement based on the responses received. All responses should be sent electronically to the designated contracting officer, with no fax submissions accepted. The contract will be performed in Bethesda, Maryland, under the Department of Health and Human Services.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Title: : Maintenance Service Contract for Illumina MiSeq and NextSeq
The Laboratory of Biochemistry and Molecular Biology (LBMB) carries out basic research into the mechanisms underlying cell growth, division, differentiation and homeostasis with a focus on the biology of chromosomes and the cell nucleus. LBMB fosters an interdisciplinary approach in which the methods of biophysics, biochemistry, genetics and cell biology are used in an interactive and collaborative research environment to solve problems of fundamental importance to cancer research. As part of this research, Next Generation Sequencing (high throughput genome-wide sequencing) is routinely performed to investigate questions relating to epigenetic regulation of the genome. The MiSeq and NextSeq machines are manufactured by Illumina and are used to obtain sequencing data for in depth genome-wide analy
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purpose of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by May 31st , 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00422 Responses may be submitted electronically to Mr. Hanumanth Rao Vishnuvajjala , Contracting Officer at vishnuh@mail.nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agenc